GOSS SCHEDULE 13G/A: SEC filing

DeepCurrents Investment Group LLC and affiliated reporting persons

Filed with the SEC on · accession 0001104659-26-128345

GOSS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. DeepCurrents Investment Group LLC and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 3.8% of Gossamer Bio's common stock, primarily through warrants exercisable within 60 days. The stock moved +0.1% by the first close after the filing.

Summary of the filing

DeepCurrents Investment Group LLC and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 3.8% of Gossamer Bio's common stock, primarily through warrants exercisable within 60 days. The filing reflects a passive investment position with no stated intent to influence control of the company.

Key details

Shares of common stock acquirable within 60 days via warrants by the Fund$178K
Shares of common stock acquirable within 60 days via warrants by a separately managed account$64K
Total shares of common stock acquirable within 60 days via warrants by reporting persons$242K
Shares of common stock outstanding as of November 7, 2026$6.1M
Reporting person / investment managerDeepCurrents Investment Group LLC
Reporting person / direct holder of warrantsDCIG Capital Master Fund LP
Reporting person / general partner of the fundDCIG GP LLC
IssuerGossamer Bio, Inc.
President and managing member of deepcurrents investment group llcKai Zheng

How GOSS stock reacted

Close before

$10.97

Nov 13, 2026

First close after

+0.09%

$10.98

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GOSS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GOSS?

Click here

Frequently asked questions

What did GOSS file with the SEC on Nov 16, 2026?

GOSS filed a SCHEDULE 13G/A (SEC filing). DeepCurrents Investment Group LLC and affiliated reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 3.8% of Gossamer Bio's common stock, primarily through warrants exercisable within 60 days. The filing reflects a passive investment position with no stated intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did GOSS stock react to this filing?

GOSS closed at $10.97 before the filing and $10.98 on Nov 16, 2026 (+0.09%).

Other GOSS SEC filings

Get alerts when GOSS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days